1921
Volume 97, Issue 2
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645

Abstract

Abstract.

In highly endemic settings for hepatitis B virus (HBV) infection such as Senegal, access to HBV prevention and care is rapidly evolving. In this context, all medical practitioners should have baseline knowledge on HBV infection and promote access to vaccination, screening, and care. A knowledge and attitudes survey on HBV infection was conducted among a randomly selected sample of medical practitioners in Senegal. Participants were asked to fill-out a questionnaire on the HBV epidemiology, prevention, and treatment. A 60-item knowledge score was computed; the lower quartile of the observed score was used to define poor knowledge. Factors associated with poor knowledge were assessed using a logistic regression model. A total of 127 medical practitioners completed the questionnaire. Only 14 (11.0%) participants knew that HBV vaccine could be safely administered to pregnant women and 65 (51.2%) to newborns. Older practitioners (> 40 years) as well as general practitioners (compared with specialists) were more likely to have a poor knowledge score with odds ratios (ORs) of 3.1 (95% confidence interval [CI] 1.0–9.2) and 2.6 (95% CI 1.0–7.3), respectively. Practitioners who declared not to recommend HBV screening frequently during their consultation were more likely to present a poor knowledge score [OR: 3.0; (95% CI 1.1–8.2)]. As universal HBV screening is being promoted in countries with endemic HBV infection, our finding that poor screening attitudes were associated with a poor knowledge is of concern. There is a need to raise awareness of medical practitioners in Senegal toward universal HBV screening and early vaccination of newborns.

Loading

Article metrics loading...

/content/journals/10.4269/ajtmh.17-0065
2017-08-02
2018-10-22
Loading full text...

Full text loading...

/deliver/fulltext/14761645/97/2/tpmd170065.html?itemId=/content/journals/10.4269/ajtmh.17-0065&mimeType=html&fmt=ahah

References

  1. Diop S, Ndiaye M, Seck M, Chevalier B, Jambou R, Sarr A, Dieye TN, Toure AO, Thiam D, Diakhate L, , 2009. Prevention of transfusion transmitted malaria in endemic area [French]. Transfus Clin Biol 16: 454459.[Crossref]
  2. Vray M, Debonne JM, Sire JM, Tran N, Chevalier B, Plantier JC, Fall F, Vernet G, Simon F, Mb PS, , 2006. Molecular epidemiology of hepatitis B virus in Dakar, Senegal. J Med Virol 78: 329334.[Crossref]
  3. Diop-Ndiaye H, Toure-Kane C, Etard JF, Lo G, Diaw P, Ngom-Gueye NF, Gueye PM, Ba-Fall K, Ndiaye I, Sow PS, Delaporte E, Mboup S, , 2008. Hepatitis B, C seroprevalence and delta viruses in HIV-1 Senegalese patients at HAART initiation (retrospective study). J Med Virol 80: 13321336.[Crossref]
  4. Mokdad AA, Lopez AD, Shahraz S, Lozano R, Mokdad AH, Stanaway J, Murray CJ, Naghavi M, , 2014. Liver cirrhosis mortality in 187 countries between 1980 and 2010: a systematic analysis. BMC Med 12: 145.[Crossref]
  5. Yang JD, Mohamed EA, Aziz AOA, Shousha HI, Hashem MB, Nabeel MM, Abdelmaksoud AH, Elbaz TM, Afihene MY, Duduyemi BM, Ayawin JP, Gyedu A, Lohouès-Kouacou M-J, Ndam AWN, Moustafa EF, Hassany SM, Moussa AM, Ugiagbe RA, Omuemu CE, Anthony R, Palmer D, Nyanga AF, Malu AO, Obekpa S, Abdo AE, Siddig AI, Mudawi HMY, Okonkwo U, Kooffreh-Ada M, Awuku YA, Nartey YA, Abbew ET, Awuku NA, Otegbayo JA, Akande KO, Desalegn HM, Omonisi AE, Ajayi AO, Okeke EN, Duguru MJ, Davwar PM, Okorie MC, Mustapha S, Debes JD, Ocama P, Lesi OA, Odeghe E, Bello R, Onyekwere C, Ekere F, Igetei R, Addissie B, Ali HM, Gores GJ, Topazian MD, Roberts LR, , 2016. Characteristics, management, and outcomes of patients with hepatocellular carcinoma in Africa: a multicountry observational study from the Africa Liver Cancer Consortium. The Lancet Gastroenterology & Hepatology 2: 103111.[Crossref]
  6. Rey-Cuille MA, Seck A, Njouom R, Chartier L, Sow HD, Mamadou Ka AS, Njankouo M, Rousset D, Giles-Vernick T, Unal G, Sire JM, Garin B, Simon F, Vray M, , 2012. Low immune response to hepatitis B vaccine among children in Dakar, Senegal. PLoS One 7: e38153.[Crossref]
  7. Bekondi C, Zanchi R, Seck A, Garin B, Giles-Vernick T, Gody JC, Bata P, Pondy A, Tetang SM, Ba M, Ekobo CS, Rousset D, Sire JM, Maylin S, Chartier L, Njouom R, Vray M, , 2015. HBV immunization and vaccine coverage among hospitalized children in Cameroon, Central African Republic and Senegal: a cross-sectional study. BMC Infect Dis 15: 267.[Crossref]
  8. Abeje G, Azage M, , 2015. Hepatitis B vaccine knowledge and vaccination status among health care workers of Bahir Dar City Administration, northwest Ethiopia: a cross sectional study. BMC Infect Dis 15: 30.[Crossref]
  9. Tatsilong HO, Noubiap JJ, Nansseu JR, Aminde LN, Bigna JJ, Ndze VN, Moyou RS, , 2016. Hepatitis B infection awareness, vaccine perceptions and uptake, and serological profile of a group of health care workers in Yaounde, Cameroon. BMC Public Health 15: 706.[Crossref]
  10. Abdela A, Woldu B, Haile K, Mathewos B, Deressa T, , 2016. Assessment of knowledge, attitudes and practices toward prevention of hepatitis B virus infection among students of medicine and health sciences in northwest Ethiopia. BMC Res Notes 9: 410.[Crossref]
  11. Mesfin YM, Kibret KT, , 2013. Assessment of knowledge and practice towards hepatitis B among medical and health science students in Haramaya University, Ethiopia. PLoS One 8: e79642.[Crossref]
  12. Adjei CA, Asamoah R, Atibila F, Ti-Enkawol GN, Ansah-Nyarko M, , 2016. Mother-to-child transmission of hepatitis B: extent of knowledge of physicians and midwives in easterregion of Ghana. BMC Public Health 16: 537.[Crossref]
  13. Chao SD, Cheung CM, Yang EJ, So SK, Chang ET, , 2012. Low levels of knowledge and preventive practices regarding vertical hepatitis B transmission among perinatal nurses. J Obstet Gynecol Neonatal Nurs 41: 494505.[Crossref]
  14. Pan CQ, Duan Z, Dai E, Zhang S, Han G, Wang Y, Zhang H, Zou H, Zhu B, Zhao W, Jiang H, , 2016. Tenofovir to prevent hepatitis B transmission in mothers with high viral load. N Engl J Med 374: 23242334.[Crossref]
  15. Giles-Vernick T, Hejoaka F, Sanou A, Shimakawa Y, Bamba I, Traore A, , 2016. Barriers to linkage to care for hepatitis B virus infection: a qualitative analysis in Burkina Faso, West Africa. Am J Trop Med Hyg 95: 13681375.
  16. WHO, 2015. Guideline on When to Start Antiretroviral Therapy and on Pre-exposure Prophylaxis for HIV. Geneva, Switzerland: World Health Organization. Available at: http://www.who.int/hiv/pub/guidelines/earlyrelease-arv/en/. Accessed December 19, 2016.
  17. Chao J, Chang ET, So SK, , 2010. Hepatitis B and liver cancer knowledge and practices among healthcare and public health professionals in China: a cross-sectional study. BMC Public Health 10: 98.[Crossref]
  18. WHO, 2016. Guidelines on Hepatitis B and C Testing, Policy Brief. Geneva, Switzerland: World Health Organization. Available at: http://www.who.int/hepatitis/publications/hepatitis-testing-recommendation-policy/en/. Accessed December 15, 2016.
  19. Burnett RJ, Francois G, Mphahlele MJ, Mureithi JG, Africa PN, Satekge MM, Mokonoto DM, Meheus A, van Sprundel M, , 2011. Hepatitis B vaccination coverage in healthcare workers in Gauteng Province, South Africa. Vaccine 29: 42934297.[Crossref]
  20. Ogoina D, Pondei K, Adetunji B, Chima G, Isichei C, Gidado S, , 2014. Prevalence of hepatitis B vaccination among health care workers in Nigeria in 2011–12. Int J Occup Environ Med 5: 5156.
  21. Kateera F, Walker TD, Mutesa L, Mutabazi V, Musabeyesu E, Mukabatsinda C, Bihizimana P, Kyamanywa P, Karenzi B, Orikiiriza JT, , 2015. Hepatitis B and C seroprevalence among health care workers in a tertiary hospital in Rwanda. Trans R Soc Trop Med Hyg 109: 203208.[Crossref]
  22. Suckling RM, Taegtmeyer M, Nguku PM, Al-Abri SS, Kibaru J, Chakaya JM, Tukei PM, Gilks CF, , 2006. Susceptibility of healthcare workers in Kenya to hepatitis B: new strategies for facilitating vaccination uptake. J Hosp Infect 64: 271277.[Crossref]
  23. Ziraba AK, Bwogi J, Namale A, Wainaina CW, Mayanja-Kizza H, , 2010. Sero-prevalence and risk factors for hepatitis B virus infection among health care workers in a tertiary hospital in Uganda. BMC Infect Dis 10: 191.[Crossref]
  24. Kaweti G, Abegaz T, , 2016. Prevalence of percutaneous injuries and associated factors among health care workers in Hawassa referral and adare District hospitals, Hawassa, Ethiopia, January 2014. BMC Public Health 16: 8.[Crossref]
  25. Bekele T, Gebremariam A, Kaso M, Ahmed K, , 2015. Factors associated with occupational needle stick and sharps injuries among hospital healthcare workers in Bale Zone, southeast Ethiopia. PLoS One 10: e0140382.[Crossref]
  26. Ngatu NR, Phillips EK, Wembonyama OS, Hirota R, Kaunge NJ, Mbutshu LH, Perry J, Yoshikawa T, Jagger J, Suganuma N, , 2012. Practice of universal precautions and risk of occupational blood-borne viral infection among Congolese health care workers. Am J Infect Control 40: 68–70 e1.
  27. Pruss-Ustun A, Rapiti E, Hutin Y, , 2005. Estimation of the global burden of disease attributable to contaminated sharps injuries among health-care workers. Am J Ind Med 48: 482490.[Crossref]
  28. Pellissier G, Yazdanpanah Y, Adehossi E, Tosini W, Madougou B, Ibrahima K, Lolom I, Legac S, Rouveix E, Champenois K, Rabaud C, Bouvet E, , 2012. Is universal HBV vaccination of healthcare workers a relevant strategy in developing endemic countries? The case of a university hospital in Niger. PLoS One 7: e44442.[Crossref]
  29. Debes JD, Kayandabila J, Pogemiller H, , 2016. Knowledge of Hepatitis B Transmission Risks Among Health Workers in Tanzania. Am J Trop Med Hyg 94: 11001102.[Crossref]
http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.17-0065
Loading
/content/journals/10.4269/ajtmh.17-0065
Loading

Data & Media loading...

Supplementary Data

Supplemental Appendix

  • Received : 26 Jan 2017
  • Accepted : 16 Mar 2017

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error